Tokio Marine Asset Management Co. Ltd. Raises Stock Holdings in Danaher Co. (NYSE:DHR)

Tokio Marine Asset Management Co. Ltd. lifted its holdings in shares of Danaher Co. (NYSE:DHR) by 5.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 15,717 shares of the conglomerate’s stock after purchasing an additional 795 shares during the quarter. Tokio Marine Asset Management Co. Ltd.’s holdings in Danaher were worth $3,636,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of DHR. Nicholas Hoffman & Company LLC. raised its stake in Danaher by 2.3% during the 4th quarter. Nicholas Hoffman & Company LLC. now owns 1,899 shares of the conglomerate’s stock valued at $439,000 after purchasing an additional 43 shares during the period. Drive Wealth Management LLC raised its stake in Danaher by 3.1% during the 4th quarter. Drive Wealth Management LLC now owns 1,485 shares of the conglomerate’s stock valued at $344,000 after purchasing an additional 44 shares during the period. Trust Investment Advisors raised its stake in Danaher by 1.8% during the 4th quarter. Trust Investment Advisors now owns 2,811 shares of the conglomerate’s stock valued at $650,000 after purchasing an additional 49 shares during the period. Connolly Sarah T. grew its holdings in Danaher by 0.5% during the 3rd quarter. Connolly Sarah T. now owns 9,599 shares of the conglomerate’s stock valued at $2,382,000 after buying an additional 50 shares in the last quarter. Finally, Austin Private Wealth LLC grew its holdings in Danaher by 3.4% during the 3rd quarter. Austin Private Wealth LLC now owns 1,566 shares of the conglomerate’s stock valued at $389,000 after buying an additional 51 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Insider Transactions at Danaher

In other news, SVP Daniel Raskas sold 23,757 shares of the business’s stock in a transaction on Monday, February 26th. The stock was sold at an average price of $252.00, for a total value of $5,986,764.00. Following the completion of the transaction, the senior vice president now directly owns 38,102 shares of the company’s stock, valued at approximately $9,601,704. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. In other news, Director Teri List sold 3,289 shares of the business’s stock in a transaction on Tuesday, February 6th. The stock was sold at an average price of $248.32, for a total value of $816,724.48. Following the completion of the transaction, the director now directly owns 19,726 shares of the company’s stock, valued at approximately $4,898,360.32. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, SVP Daniel Raskas sold 23,757 shares of the business’s stock in a transaction on Monday, February 26th. The stock was sold at an average price of $252.00, for a total value of $5,986,764.00. Following the transaction, the senior vice president now owns 38,102 shares in the company, valued at $9,601,704. The disclosure for this sale can be found here. In the last three months, insiders sold 32,957 shares of company stock valued at $8,265,802. Corporate insiders own 10.90% of the company’s stock.

Danaher Stock Down 1.1 %

NYSE DHR traded down $2.70 on Wednesday, reaching $250.41. 3,064,441 shares of the stock traded hands, compared to its average volume of 2,783,958. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.37 and a current ratio of 1.68. The company has a fifty day moving average price of $249.00 and a 200-day moving average price of $230.78. The company has a market cap of $185.44 billion, a price-to-earnings ratio of 39.19, a PEG ratio of 3.96 and a beta of 0.83. Danaher Co. has a 12 month low of $182.09 and a 12 month high of $259.00.

Danaher (NYSE:DHR) last issued its earnings results on Tuesday, April 23rd. The conglomerate reported $1.92 earnings per share for the quarter, beating analysts’ consensus estimates of $1.72 by $0.20. The business had revenue of $5.80 billion during the quarter, compared to analyst estimates of $5.62 billion. Danaher had a return on equity of 12.25% and a net margin of 17.26%. Danaher’s revenue was down 2.6% on a year-over-year basis. During the same period in the previous year, the company posted $2.36 EPS. As a group, research analysts forecast that Danaher Co. will post 7.62 EPS for the current fiscal year.

Danaher Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 26th. Shareholders of record on Thursday, March 28th will be given a dividend of $0.27 per share. The ex-dividend date is Wednesday, March 27th. This is a positive change from Danaher’s previous quarterly dividend of $0.24. This represents a $1.08 dividend on an annualized basis and a yield of 0.43%. Danaher’s payout ratio is 16.90%.

Analysts Set New Price Targets

Several equities analysts have weighed in on the company. Royal Bank of Canada raised their price target on Danaher from $254.00 to $282.00 and gave the company an “outperform” rating in a report on Wednesday, January 31st. HSBC upgraded Danaher from a “hold” rating to a “buy” rating and raised their price target for the company from $250.00 to $280.00 in a report on Wednesday, April 17th. TD Cowen lifted their target price on Danaher from $280.00 to $290.00 and gave the stock a “buy” rating in a report on Wednesday. Barclays lifted their target price on Danaher from $260.00 to $270.00 and gave the stock an “equal weight” rating in a report on Wednesday. Finally, Citigroup lifted their target price on Danaher from $280.00 to $290.00 and gave the stock a “buy” rating in a report on Wednesday. Six investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $270.00.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.